Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1972;47(5):559–565.

A consideration of the economic impact of schistosomiasis*

W H Wright
PMCID: PMC2480844  PMID: 4540674

Abstract

An attempt is made to estimate the economic effects of schistosomiasis, a disease known to be endemic in 71 countries or islands with a total population of about 1 362 million persons, of whom approximately 124 905 800 are infected. These data are based on prevalence rates representing, for the most part, single stool or urine examinations; the actual number of cases is undoubtedly much greater. This analysis refers only to resource loss attributable to reduced productivity. The annual loss from complete and partial disability is estimated to be US $445 866 945 in Africa, US $755 480 in Mauritius, US $16 527 275 in South-West Asia, US $118 143 675 in South-East Asia, and US $60 496 755 for the Americas. The total estimated annual world loss amounts to US $641 790 130 but this sum does not include the cost of public health programmes, medical care, or compensation for illness.

Full text

PDF
561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbosa F. A. Morbidade da esquistossomose. Rev Bras Malariol Doencas Trop. 1966;(Suppl):3–159. [PubMed] [Google Scholar]
  2. Cheever A. W. A quantitative post-mortem study of Schistosomiasis mansoni in man. Am J Trop Med Hyg. 1968 Jan;17(1):38–64. doi: 10.4269/ajtmh.1968.17.38. [DOI] [PubMed] [Google Scholar]
  3. FAROOQ M. MEDICAL AND ECONOMIC IMPORTANCE OF SCHISTOSOMIASIS. J Trop Med Hyg. 1964 May;67:105–112. [PubMed] [Google Scholar]
  4. Farooq M., Nielsen J., Samaan S. A., Mallah M. B., Allam A. A. The epidemiology of Schistosoma haematobium and S. mansoni infections in the Egypt-49 project area. 2. Prevalence of bilharziasis in relation to personal attributes and habits. Bull World Health Organ. 1966;35(3):293–318. [PMC free article] [PubMed] [Google Scholar]
  5. Farooq M. Progress in bilharziasis control. The situation in Egypt. WHO Chron. 1967 May;21(5):175–184. [PubMed] [Google Scholar]
  6. Forsyth D. M., MacDonald G. Urological complications of endemic schistosomiasis in schoolchildren. 2. Donge school, Zanzibar. Trans R Soc Trop Med Hyg. 1966;60(5):568–578. doi: 10.1016/0035-9203(66)90002-2. [DOI] [PubMed] [Google Scholar]
  7. HERTWIG F., OBERDOERSTER F. [Contribution to some problems of parasitic diseases in China. I. Schistosomiasis]. Z Tropenmed Parasitol. 1960 Oct;11:324–335. [PubMed] [Google Scholar]
  8. KLOETZEL K. NATURAL HISTORY AND PROGNOSIS OF SPLENOMEGALY IN SCHISTOSOMIASIS MANSONI. Am J Trop Med Hyg. 1964 Jul;13:541–544. doi: 10.4269/ajtmh.1964.13.541. [DOI] [PubMed] [Google Scholar]
  9. MAEGRAITH B. Schistosomiasis in China. Lancet. 1958 Jan 25;1(7013):208–214. doi: 10.1016/s0140-6736(58)90686-x. [DOI] [PubMed] [Google Scholar]
  10. MUSHKIN S. J., COLLINGS F. D. Economic costs of disease and injury. Public Health Rep. 1959 Sep;74:795–809. [PMC free article] [PubMed] [Google Scholar]
  11. WRIGHT W. H. Bilharziasis as a public health problem in the Pacific. Bull World Health Organ. 1950;2(4):581–595. [PMC free article] [PubMed] [Google Scholar]
  12. Wright W. H. Schistosomiasis as a world problem. Bull N Y Acad Med. 1968 Mar;44(3):301–312. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES